XML 122 R105.htm IDEA: XBRL DOCUMENT v3.24.3
Supplemental Financial Information - Cash Flows (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Cash flows from operating activities          
Net income $ 615.7 $ 111.0 $ 863.8 $ 173.6  
Adjustments to reconcile net income to net cash flows from operating activities:          
Depreciation and amortization     137.0 137.0  
Equity-based compensation 121.6 64.4 355.1 186.8  
Non-cash performance allocations and incentive fees     (387.9) 427.3  
Non-cash principal investment income     (188.4) (91.6)  
Other non-cash amounts     15.8 8.1  
Purchases of investments     (213.8) (221.3)  
Proceeds from the sale of investments     333.3 338.4  
Payments of contingent consideration     (4.0) (68.6)  
Changes in deferred taxes, net     98.3 (103.3)  
Change in due from affiliates and other receivables     (40.1) 16.7  
Change in deposits and other     (5.4) (38.5)  
Change in accounts payable, accrued expenses and other liabilities     15.4 (101.8)  
Change in accrued compensation and benefits     (170.8) (128.3)  
Change in due to affiliates     (0.9) (8.8)  
Change in lease right-of-use asset and lease liability     (5.4) (7.5)  
Change in deferred revenue     238.1 290.0  
Net cash used in operating activities     (406.7) (49.2)  
Cash flows from investing activities          
Purchases of corporate treasury investments     (5.0) (187.3)  
Proceeds from corporate treasury investments     5.1 152.4  
Purchases of fixed assets, net     (51.0) (49.6)  
Net cash used in investing activities     (50.9) (84.5)  
Cash flows from financing activities          
Borrowings under credit facilities     10.4 0.0  
Repayments under credit facilities     (10.4) 0.0  
Payments on CLO borrowings     (73.3) (7.3)  
Proceeds from CLO borrowings, net of financing costs     0.5 10.0  
Dividends to common stockholders     (377.8) (371.4)  
Payment of deferred consideration for Carlyle Holdings units     (68.8) (68.8)  
Contributions from non-controlling interest holders     219.2 99.0  
Distributions to non-controlling interest holders     (73.0) (99.7)  
Common shares repurchased and net share settlement of equity awards     (478.8) (203.7)  
Change in due to/from affiliates financing activities     2.2 (82.7)  
Net cash provided by financing activities     370.7 52.6  
Effect of foreign exchange rate changes     23.7 (8.2)  
Decrease in cash, cash equivalents and restricted cash     (63.2) (89.3)  
Cash, cash equivalents and restricted cash, beginning of period     1,442.1 1,361.5  
Cash, cash equivalents and restricted cash, end of period 1,378.9 1,272.2 1,378.9 1,272.2  
Reconciliation of cash, cash equivalents and restricted cash, end of period:          
Cash and cash equivalents 1,376.8 1,267.7 1,376.8 1,267.7 $ 1,440.3
Restricted cash 2.1 4.5 2.1 4.5 1.8
Total cash, cash equivalents and restricted cash, end of period 1,378.9 1,272.2 1,378.9 1,272.2 1,442.1
Cash and cash equivalents held at Consolidated Funds 488.5 352.3 488.5 352.3 346.0
Consolidated Operating Entities          
Cash flows from operating activities          
Net income     847.1 104.9  
Adjustments to reconcile net income to net cash flows from operating activities:          
Depreciation and amortization     137.0 137.0  
Equity-based compensation     355.1 186.8  
Non-cash performance allocations and incentive fees     (389.1) 425.0  
Non-cash principal investment income     (182.0) (100.0)  
Other non-cash amounts     15.8 8.1  
Purchases of investments     (479.4) (244.9)  
Proceeds from the sale of investments     435.7 351.8  
Payments of contingent consideration     (4.0) (68.6)  
Changes in deferred taxes, net     98.3 (103.3)  
Change in due from affiliates and other receivables     (38.2) 16.9  
Change in deposits and other     (5.4) (38.5)  
Change in accounts payable, accrued expenses and other liabilities     15.4 (101.8)  
Change in accrued compensation and benefits     (170.8) (128.3)  
Change in due to affiliates     (0.9) (8.8)  
Change in lease right-of-use asset and lease liability     (5.4) (7.5)  
Change in deferred revenue     238.1 290.0  
Net cash used in operating activities     867.3 718.8  
Cash flows from investing activities          
Purchases of corporate treasury investments     (5.0) (187.3)  
Proceeds from corporate treasury investments     5.1 152.4  
Purchases of fixed assets, net     (51.0) (49.6)  
Net cash used in investing activities     (50.9) (84.5)  
Cash flows from financing activities          
Borrowings under credit facilities     10.4 0.0  
Repayments under credit facilities     (10.4) 0.0  
Payments on CLO borrowings     (73.3) (7.3)  
Proceeds from CLO borrowings, net of financing costs     0.5 10.0  
Dividends to common stockholders     (377.8) (371.4)  
Payment of deferred consideration for Carlyle Holdings units     (68.8) (68.8)  
Contributions from non-controlling interest holders     155.2 7.9  
Distributions to non-controlling interest holders     (58.9) (48.9)  
Common shares repurchased and net share settlement of equity awards     (478.8) (203.7)  
Change in due to/from affiliates financing activities     13.3 (36.4)  
Net cash provided by financing activities     (888.6) (718.6)  
Effect of foreign exchange rate changes     9.0 (5.0)  
Decrease in cash, cash equivalents and restricted cash     (63.2) (89.3)  
Cash, cash equivalents and restricted cash, beginning of period     1,442.1 1,361.5  
Cash, cash equivalents and restricted cash, end of period 1,378.9 1,272.2 1,378.9 1,272.2  
Reconciliation of cash, cash equivalents and restricted cash, end of period:          
Cash and cash equivalents 1,376.8 1,267.7 1,376.8 1,267.7  
Restricted cash 2.1 4.5 2.1 4.5  
Total cash, cash equivalents and restricted cash, end of period 1,378.9 1,272.2 1,378.9 1,272.2 $ 1,442.1
Cash and cash equivalents held at Consolidated Funds $ 488.5 $ 352.3 $ 488.5 $ 352.3